Perspective Therapeutics Inc
CATX3.730USD
+0.050+1.36%
交易中 （美东）报价延迟15分钟
276.21M总市值
亏损市盈率 TTM
关于 Perspective Therapeutics Inc 公司
Perspective Therapeutics, Inc. 是一家放射性药物开发公司，正在开发针对全身癌症的先进治疗应用。该公司拥有专有技术，利用发射α同位素212Pb通过专门的靶向肽向癌细胞提供强大的辐射。该公司还在开发结合相同靶向肽的成像诊断技术，这为个性化治疗和优化患者结果提供了机会。这种治疗诊断方法能够看到特定的肿瘤，然后对其进行治疗，从而有可能提高疗效并最大限度地降低毒性。该公司的黑色素瘤 (VMT01) 和神经内分泌肿瘤 (VMT-α-NET) 项目已进入 I/IIa 期成像和治疗试验，用于治疗转移性黑色素瘤和神经内分泌肿瘤，试验地点在几所学术机构。该公司还开发了 212Pb 发生器，以确保临床试验和商业运营的关键同位素。
公司简介
公司代码CATX
公司名称Perspective Therapeutics Inc
上市日期May 31, 2002
CEOMr. Johan M. (Thijs) Spoor
员工数量138
证券类型Ordinary Share
年结日May 31
公司地址2401 Elliott Avenue
城市SEATTLE
上市交易所NYSE American Consolidated
国家United States of America
邮编98121
电话12066760900
网址https://www.perspectivetherapeutics.com/
公司代码CATX
上市日期May 31, 2002
CEOMr. Johan M. (Thijs) Spoor
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Markus Puhlmann, M.D.
Dr. Markus Puhlmann, M.D.
Chief Medical Officer
Chief Medical Officer
137.54K
--
Mr. Johan M. (Thijs) Spoor
Mr. Johan M. (Thijs) Spoor
Chief Executive Officer, Director
Chief Executive Officer, Director
87.68K
+72.66%
Mr. Jonathan Robert Hunt
Mr. Jonathan Robert Hunt
Chief Accounting Officer
Chief Accounting Officer
48.80K
--
Mr. Juan Graham
Mr. Juan Graham
Chief Financial Officer
Chief Financial Officer
35.35K
+1649.33%
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
25.98K
--
Dr. Frank Morich, M.D., Ph.D.
Dr. Frank Morich, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert Froman Williamson, III
Mr. Robert Froman Williamson, III
Independent Director
Independent Director
--
--
Ms. Lori A. Woods
Ms. Lori A. Woods
Chairman of the Board
Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Markus Puhlmann, M.D.
Dr. Markus Puhlmann, M.D.
Chief Medical Officer
Chief Medical Officer
137.54K
--
Mr. Johan M. (Thijs) Spoor
Mr. Johan M. (Thijs) Spoor
Chief Executive Officer, Director
Chief Executive Officer, Director
87.68K
+72.66%
Mr. Jonathan Robert Hunt
Mr. Jonathan Robert Hunt
Chief Accounting Officer
Chief Accounting Officer
48.80K
--
Mr. Juan Graham
Mr. Juan Graham
Chief Financial Officer
Chief Financial Officer
35.35K
+1649.33%
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
25.98K
--
Dr. Frank Morich, M.D., Ph.D.
Dr. Frank Morich, M.D., Ph.D.
Independent Director
Independent Director
--
--
收入明细
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
342.00K
0.00%
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Lantheus Holdings, Inc.
15.73%
Fidelity Management & Research Company LLC
10.58%
BlackRock Institutional Trust Company, N.A.
4.98%
The Vanguard Group, Inc.
4.13%
Deerfield Management Company, L.P.
3.81%
Other
60.76%
持股股东
持股股东
占比
Lantheus Holdings, Inc.
15.73%
Fidelity Management & Research Company LLC
10.58%
BlackRock Institutional Trust Company, N.A.
4.98%
The Vanguard Group, Inc.
4.13%
Deerfield Management Company, L.P.
3.81%
Other
60.76%
股东类型
持股股东
占比
Investment Advisor
32.07%
Hedge Fund
17.16%
Corporation
15.73%
Investment Advisor/Hedge Fund
6.89%
Research Firm
3.49%
Individual Investor
3.14%
Bank and Trust
1.48%
Pension Fund
0.08%
Insurance Company
0.02%
Other
19.93%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
302
59.45M
80.09%
-11.86M
2025Q1
304
60.05M
85.30%
-5.99M
2024Q4
290
62.49M
92.46%
-2.78M
2024Q3
266
63.29M
93.81%
+14.81M
2024Q2
218
52.68M
78.08%
+17.83M
2024Q1
143
38.70M
62.94%
+26.72M
2023Q4
99
10.58M
37.69%
+4.15M
2023Q3
101
10.50M
37.42%
+4.44M
2023Q2
99
3.54M
12.59%
+269.05K
2023Q1
108
3.01M
11.39%
+817.81K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Lantheus Holdings, Inc.
11.68M
15.73%
--
--
Apr 02, 2025
Fidelity Management & Research Company LLC
7.86M
10.58%
+72.66K
+0.93%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.70M
4.98%
-33.85K
-0.91%
Mar 31, 2025
The Vanguard Group, Inc.
3.07M
4.13%
-65.21K
-2.08%
Mar 31, 2025
Deerfield Management Company, L.P.
2.83M
3.81%
-109.34K
-3.72%
Mar 31, 2025
Octagon Capital Advisors LP
2.25M
3.03%
-54.75K
-2.38%
Mar 31, 2025
Affinity Asset Advisors LLC
2.22M
3%
+924.20K
+71.09%
Mar 31, 2025
Avidity Partners Management LP
2.20M
2.96%
-497.33K
-18.46%
Mar 31, 2025
Fidelity Institutional Asset Management
2.20M
2.96%
-49.22K
-2.19%
Mar 31, 2025
Nicholson Wealth Management Group, LLC
1.61M
2.17%
--
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Fidelity Fundamental Small-Mid Cap ETF
0.06%
iShares Micro-Cap ETF
0.05%
iShares Russell 2000 Value ETF
0.02%
iShares Biotechnology ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Fidelity Fundamental Small-Mid Cap ETF
占比0.06%
iShares Micro-Cap ETF
占比0.05%
iShares Russell 2000 Value ETF
占比0.02%
iShares Biotechnology ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
公告日期
类型
比率
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
Apr 09, 2024
Merger
10<1
